Astera Labs [ALAB] vs Nvidia [NVDA] Detailed Stock Comparison
Astera Labs
NASDAQ
Loading...
Nvidia
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Astera Labs wins in 5 metrics, Nvidia wins in 13 metrics, with 0 ties. Nvidia appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astera Labs | Nvidia | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 232.31 | 56.84 | Nvidia |
| Price-to-Book Ratio | 27.20 | 51.09 | Astera Labs |
| Debt-to-Equity Ratio | 2.85 | 12.27 | Astera Labs |
| PEG Ratio | -0.32 | 2.07 | Astera Labs |
| EV/EBITDA | 640.11 | 49.83 | Nvidia |
| Profit Margin (TTM) | 16.54% | 51.69% | Nvidia |
| Operating Margin (TTM) | 20.72% | 49.11% | Nvidia |
| EBITDA Margin (TTM) | 20.72% | 49.11% | Nvidia |
| Return on Equity | 10.11% | 115.46% | Nvidia |
| Return on Assets (TTM) | 2.42% | 53.24% | Nvidia |
| Free Cash Flow (TTM) | $102.43M | $60.85B | Nvidia |
| Dividend Yield | N/A | 0.03% | N/A |
| 1-Year Return | 325.02% | 35.26% | Astera Labs |
| Price-to-Sales Ratio (TTM) | 51.01 | 28.84 | Nvidia |
| Enterprise Value | $29.86B | $4,397.64B | Nvidia |
| EV/Revenue Ratio | 49.31 | 29.61 | Nvidia |
| Gross Profit Margin (TTM) | 75.84% | 60.52% | Astera Labs |
| Revenue per Share (TTM) | $4 | $6 | Nvidia |
| Earnings per Share (Diluted) | $0.80 | $3.09 | Nvidia |
| Beta (Stock Volatility) | N/A | 2.15 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Astera Labs vs Nvidia Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astera Labs | 2.95% | -6.90% | 45.65% | 92.61% | 107.10% | 31.87% |
| Nvidia | -0.24% | -3.87% | 2.10% | 32.76% | 30.16% | 26.51% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astera Labs | 325.02% | 153.61% | 153.61% | 153.61% | 153.61% | 153.61% |
| Nvidia | 35.26% | 976.14% | 1,230.65% | 30,598.25% | 69,892.00% | 72,808.33% |
Performance & Financial Health Analysis: Astera Labs vs Nvidia
| Metric | ALAB | NVDA |
|---|---|---|
| Market Information | ||
| Market Cap | $30.89B | $4.28T |
| Market Cap Category | Large cap | Mega cap |
| 10 Day Avg. Volume | 7,127,150 | 147,750,345 |
| 90 Day Avg. Volume | 6,149,653 | 159,235,442 |
| Last Close | $177.53 | $174.98 |
| 52 Week Range | $36.85 - $199.47 | $86.62 - $184.48 |
| % from 52W High | -11.00% | -5.15% |
| All-Time High | $193.77 (Aug 12, 2025) | $184.48 (Aug 12, 2025) |
| % from All-Time High | -8.38% | -5.15% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.50% | 0.69% |
| Quarterly Earnings Growth | 1.50% | 0.26% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.52% |
| Operating Margin (TTM) | 0.21% | 0.49% |
| Return on Equity (TTM) | 0.10% | 1.15% |
| Debt to Equity (MRQ) | 2.85 | 12.27 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.83 | $3.44 |
| Cash per Share (MRQ) | $6.41 | $2.20 |
| Operating Cash Flow (TTM) | $249.08M | $76.16B |
| Levered Free Cash Flow (TTM) | $148.11M | $55.44B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.03% |
| Last 12-Month Dividend | N/A | $0.04 |
Valuation & Enterprise Metrics Analysis: Astera Labs vs Nvidia
| Metric | ALAB | NVDA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 232.31 | 56.84 |
| Forward P/E | 161.61 | 42.63 |
| PEG Ratio | -0.32 | 2.07 |
| Price to Sales (TTM) | 51.01 | 28.84 |
| Price to Book (MRQ) | 27.20 | 51.09 |
| Market Capitalization | ||
| Market Capitalization | $30.89B | $4.28T |
| Enterprise Value | $29.86B | $4.40T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 49.31 | 29.61 |
| Enterprise to EBITDA | 640.11 | 49.83 |
| Risk & Other Metrics | ||
| Beta | N/A | 2.15 |
| Book Value per Share (MRQ) | $6.83 | $3.44 |
Financial Statements Comparison: Astera Labs vs Nvidia
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALAB | NVDA |
|---|---|---|
| Revenue/Sales | $159.44M | $44.06B |
| Cost of Goods Sold | $40.03M | $17.39B |
| Gross Profit | $119.41M | $26.67B |
| Research & Development | $64.55M | $3.99B |
| Operating Income (EBIT) | $11.29M | $21.64B |
| EBITDA | $12.41M | $22.58B |
| Pre-Tax Income | $21.72M | $21.91B |
| Income Tax | $-10.10M | $3.14B |
| Net Income (Profit) | $31.82M | $18.78B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALAB | NVDA |
|---|---|---|
| Cash & Equivalents | $162.33M | $15.23B |
| Total Current Assets | $1.18B | $89.94B |
| Total Current Liabilities | $106.38M | $26.54B |
| Long-Term Debt | N/A | $9.99B |
| Total Shareholders Equity | $1.14B | $83.84B |
| Retained Earnings | $-125.76M | $72.16B |
| Property, Plant & Equipment | $16.48M | $8.95B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALAB | NVDA |
|---|---|---|
| Operating Cash Flow | $38.84M | $19.55B |
| Capital Expenditures | $-4.54M | $-1.23B |
| Free Cash Flow | $5.97M | $26.19B |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-14.10B |
Short Interest & Institutional Ownership Analysis
| Metric | ALAB | NVDA |
|---|---|---|
| Shares Short | 9.28M | 192.12M |
| Short Ratio | 1.77 | 1.17 |
| Short % of Float | 0.08% | 0.01% |
| Average Daily Volume (10 Day) | 7,127,150 | 147,750,345 |
| Average Daily Volume (90 Day) | 6,149,653 | 159,235,442 |
| Shares Outstanding | 162.02M | 24.48B |
| Float Shares | 134.29M | 23.42B |
| % Held by Insiders | 0.13% | 0.04% |
| % Held by Institutions | 0.72% | 0.69% |
Dividend Analysis & Yield Comparison: Astera Labs vs Nvidia
| Metric | ALAB | NVDA |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.04 |
| Last 12-Month Dividend Yield | N/A | 0.03% |
| 3-Year Avg Annual Dividend | N/A | $0.02 |
| 3-Year Avg Dividend Yield | N/A | 0.01% |
| 3-Year Total Dividends | N/A | $0.05 |
| Ex-Dividend Date | N/A | Jun 11, 2025 |